Illumina has been tracing out a narrow consolidation pattern for the last seven weeks. Yesterday’s impressive 4.25% gain, which was the second-best performance in the Nasdaq 100, may soon spark an end to this bullish pennant formation with a fresh rally leg.
Category: Scientific Instruments
II-VI’s Optics Are Excellent
In this one-year daily chart of IIVI, below, we can see how prices started their uptrend in September. Prices are above the rising 50-week moving average line and the rising 200-day average.
Why Allegheny Technologies, II-VI, and Beazer Homes Jumped Today
The stock market performed well on Tuesday, responding to steady improvement among many companies as earnings season kicked into high gear. Although political issues are likely to remain in the spotlight for some investors for the foreseeable future, many market participants are looking to economic and business issues in driving their investing decisions.
Continental Resources, Inc. Doubled in 2016. Is There Anything Left for 2017?
Those improvements, combined with rising oil prices and strong well results from an emerging growth play, catapulted the company’s stock: Thanks to those gains, Continental Resources’ stock ended the year just 36% below its all-time high, which it set right before oil prices started crumbling in 2014. While a return of triple-digit oil is unlikely for quite some time, Continental Resources does not need oil that high to thrive in the future, thanks to its improving drilling results.
Is Danaher Corporation Stock a Buy for 2017?
A heavy exposure to healthcare and environmental solutions used to make it the go-to stock when analysts were concerned about an economic downturn. Furthermore, the more cyclical bits of the business have been bundled together and spun off into a new company called , leaving Danaher even more exposed to non-cyclical end markets.
InvenSense’s Stock Soars To Lead NYSE Gainers After TDK Merger Deal
InvenSense Inc.’s stock soared 17% toward a 16-month high in morning trade Wednesday, enough to be the top gainer on the NYSE, after the sensor platform maker agreed to be acquired by Japan’s TDK Corp. in a deal valued at $1.3 billion. Under terms of the deal, TDK will pay $13 for each InvenSense share, a 20% premium to Tuesday’s closing price of $10.84.
Harvard Bioscience an ‘Asymmetrical Long Shot’
One of the best parts of writing for Real Money is all the great people I get to meet. I have made some great friends with fellow contributors and Real Money subscribers over the years, and I enjoy hearing from everyone who writes and comments on my articles.